Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs

EASL Recommendations on Treatment of Hepatitis C 2015

(2015)   JOURNAL OF HEPATOLOGY

Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review

(2014) A. Cousien et al.   JOURNAL OF VIRAL HEPATITIS

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

(2014) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

(2013) Adriaan J. van der Meer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

(2013) Eric Lawitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C Transmission and Treatment in Contact Networks of People Who Inject Drugs

(2013) David A. Rolls et al.   PLoS One

Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study

(2012) Norah A. Terrault et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2011)   JOURNAL OF HEPATOLOGY

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

(2011) Paul K Nelson et al.   LANCET

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

(2011) Markus Cornberg et al.   LIVER INTERNATIONAL

Approximate Bayesian computational methods

(2011) Jean-Michel Marin et al.   STATISTICS AND COMPUTING

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study

(2010) Pascal Melin et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors

(2010) Christine Meffre et al.   JOURNAL OF MEDICAL VIROLOGY

Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?

(2009) M. J. Sweeting et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design

(2009) Marie Jauffret-Roustide et al.   BMC INFECTIOUS DISEASES

Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place

(2008) H. Hagan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Capture–recapture estimates of the local prevalence of problem drug use in six French cities

(2008) Laure Vaissade et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

(2008) Campbell Kynoch Aitken et al.   HEPATOLOGY

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY